Related Experiment Video

Updated: Jul 13, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Is it possible to predict which patients need distal protection during primary angioplasty?

Hisashi Umeda1, Mitsunori Iwase, Hideo Izawa

  • 1Division of Cardiology, Toyota Memorial Hospital, 1-1 Heiwa-cho, Toyota 471-8513, Japan. humedamd@ybb.ne.jp

International Journal of Cardiology
|August 11, 2007
PubMed

Insights

Distal protection devices (DP) during primary percutaneous coronary intervention (PCI) improve outcomes for specific ST-segment elevation myocardial infarction (STEMI) patients. These devices reduce complications and infarct size in those with right coronary artery lesions, large thrombi, or large infarct-related arteries.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Management

Background:

  • The clinical utility of distal protection (DP) devices during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is debated.
  • Identifying patient subgroups who benefit from DP is crucial for optimizing treatment strategies.
  • This study investigates clinical and angiographic predictors of DP benefit in STEMI patients undergoing primary PCI.

Purpose of the Study:

  • To determine which clinical and angiographic characteristics identify STEMI patients who benefit from distal protection (DP) during primary PCI.
  • To evaluate the impact of DP on reperfusion rates, thromboembolic complications, and infarct size in specific STEMI patient subgroups.

Main Methods:

  • A comparative study involving 103 STEMI patients treated with primary PCI and DP.
  • Comparison group comprised 98 STEMI patients treated with primary PCI alone.
  • Outcomes assessed included rates of thromboembolic complications, optimal reperfusion (myocardial blush grade ≥2 and ST-segment resolution ≥70%), and infarct size.

Main Results:

  • Overall, DP use did not significantly differ in reducing thromboembolic complications or improving reperfusion and infarct size compared to PCI alone.
  • However, DP was associated with significantly higher rates of optimal reperfusion in patients with right coronary artery (RCA) lesions (OR 2.45), thrombus score ≥4 (OR 2.64), or large infarct-related artery (IRA) diameter ≥3.5 mm (OR 4.09).
  • In these specific subgroups (RCA lesions, high thrombus score, or large IRA), DP use significantly reduced thromboembolic complications and infarct size.

Conclusions:

  • Distal protection (DP) devices may be beneficial in primary PCI for STEMI patients with specific characteristics.
  • Patients with right coronary artery (RCA) culprit lesions, a large thrombus burden, or a large infarct-related artery (IRA) diameter demonstrated improved outcomes with DP.
  • These findings suggest that DP can reduce thromboembolic complications, enhance reperfusion, and minimize infarct size in selected STEMI populations.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...